131 related articles for article (PubMed ID: 19758098)
1. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
Quan Y; Liang C; Brenner BG; Wainberg MA
J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
[TBL] [Abstract][Full Text] [Related]
2. Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV.
Quan Y; Xu H; Wainberg MA
J Antimicrob Chemother; 2014 Jan; 69(1):21-7. PubMed ID: 23963235
[TBL] [Abstract][Full Text] [Related]
3. Variations in reverse transcriptase and RNase H domain mutations in human immunodeficiency virus type 1 clinical isolates are associated with divergent phenotypic resistance to zidovudine.
Ntemgwa M; Wainberg MA; Oliveira M; Moisi D; Lalonde R; Micheli V; Brenner BG
Antimicrob Agents Chemother; 2007 Nov; 51(11):3861-9. PubMed ID: 17724152
[TBL] [Abstract][Full Text] [Related]
4. Competitive capacity of HIV-1 strains carrying M184I or Y181I drug-resistant mutations.
Li J; Li L; Li HP; Zhuang DM; Liu SY; Liu YJ; Bao ZY; Wang Z; Li JY
Chin Med J (Engl); 2009 May; 122(9):1081-6. PubMed ID: 19493444
[TBL] [Abstract][Full Text] [Related]
5. The ratio of defective HIV-1 particles to replication-competent infectious virions.
Bourinbaiar AS
Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666
[TBL] [Abstract][Full Text] [Related]
6. The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.
Blick G; Kagan RM; Coakley E; Petropoulos C; Maroldo L; Greiger-Zanlungo P; Gretz S; Garton T
J Infect Dis; 2007 May; 195(9):1250-9. PubMed ID: 17396993
[TBL] [Abstract][Full Text] [Related]
7. Drug induced superinfection in HIV and the evolution of drug resistance.
Leontiev VV; Maury WJ; Hadany L
Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
[TBL] [Abstract][Full Text] [Related]
8. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
[TBL] [Abstract][Full Text] [Related]
9. Production of infectious particles from defective human immunodeficiency virus type 1 (HIV-1)-producing cell clones by superinfection with infectious HIV-1.
Yunoki M; Maotani-Imai K; Kusuda H; Motoyama M; Miyake S; Imai H; Shin YS; Kato S; Sano K; Morita C
Arch Virol; 1991; 116(1-4):143-58. PubMed ID: 2001175
[TBL] [Abstract][Full Text] [Related]
10. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1.
Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K
Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 intra-subtype superinfection rates: estimates using a structured coalescent with recombination.
Taylor JE; Korber BT
Infect Genet Evol; 2005 Jan; 5(1):85-95. PubMed ID: 15567142
[TBL] [Abstract][Full Text] [Related]
12. Multidrug-resistant HIV-1 RNA and proviral DNA variants harboring new dipeptide insertions in the reverse transcriptase pol gene.
Andréoletti L; Weiss L; Si-Mohamed A; Piketty C; Prazuck T; Calamy G; Malkin JE; Matta M; Mbopi-Kéou FX; Clavel F; Kazatchkine MD; Bélec L
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):102-4. PubMed ID: 11782598
[No Abstract] [Full Text] [Related]
13. Reversion of a polymerase-defective integrated HIV-1 genome.
Quillent C; Dumey N; Dauguet C; Clavel F
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1031-7. PubMed ID: 7506552
[TBL] [Abstract][Full Text] [Related]
14. The involvement of HIV-1 RNAse H in resistance to nucleoside analogues.
Roquebert B; Marcelin AG
J Antimicrob Chemother; 2008 May; 61(5):973-5. PubMed ID: 18325896
[TBL] [Abstract][Full Text] [Related]
15. Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients.
Pollicino T; Isgrò G; Di Stefano R; Ferraro D; Maimone S; Brancatelli S; Squadrito G; Di Marco V; Craxì A; Raimondo G
Antivir Ther; 2009; 14(5):649-54. PubMed ID: 19704167
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences.
Blackard JT; Cohen DE; Mayer KH
Clin Infect Dis; 2002 Apr; 34(8):1108-14. PubMed ID: 11915000
[TBL] [Abstract][Full Text] [Related]
17. Recombination in HIV: an important viral evolutionary strategy.
Burke DS
Emerg Infect Dis; 1997; 3(3):253-9. PubMed ID: 9284369
[TBL] [Abstract][Full Text] [Related]
18. Persistence of multidrug-resistant HIV-1 in primary infection leading to superinfection.
Brenner B; Routy JP; Quan Y; Moisi D; Oliveira M; Turner D; Wainberg MA;
AIDS; 2004 Aug; 18(12):1653-60. PubMed ID: 15280776
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 resistance to first- and second-generation non-nucleoside reverse transcriptase inhibitors.
Ghosn J; Chaix ML; Delaugerre C
AIDS Rev; 2009; 11(3):165-73. PubMed ID: 19654858
[TBL] [Abstract][Full Text] [Related]
20. Generation of H9 T-cells stably expressing a membrane-bound form of the cytoplasmic tail of the Env-glycoprotein: lack of transcomplementation of defective HIV-1 virions encoding C-terminally truncated Env.
Holtkotte D; Pfeiffer T; Bosch V
Retrovirology; 2006 May; 3():27. PubMed ID: 16700925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
